Maria Eagle MP: written questions
4 Jul 2026–22 Nov 2026 · year in progress
How these years work
Our reporting years run from 4 July to 3 July, starting with the 2024 general election. They are not official parliamentary sessions. Office costs keep IPSA’s April–March financial years. Records may cover only part of a year; a missing record does not mean no work was done.
Written questions: dates and coverage
- Source checked
- 21 Nov 2026
- Last successful import
- 21 Nov 2026
- Records dated through
- 20 Nov 2026
- Selected period
- Reporting year 3: 4 Jul 2026 to 22 Nov 2026
- Completeness
- Published snapshot: 25,747 records in the source window 23 Aug 2026 to 21 Nov 2026. The published snapshot covers its stated source window. Answers and corrections can appear later; no indexed answer does not prove that none exists.
Understand written questions, dates and answers.
Read what this MP said, asked and contributed in Parliament.
11 published records · newest first.
Written questions
Friedreich's Ataxia: DrugsDepartment of Health and Social CareTabled 10 Nov 2026AnsweredUIN 41440More
Question: To ask the Secretary of State for Health and Social Care, if she will publish a timeline for a decision on routine NHS access to treatment for Friedreich's Ataxia.
Answer: I refer the Rt Hon. Member to the answer provided on 26 October in response to Question 36046.At the request of Biogen, NHS England has offered to hold a commercial surgery with the company in December, which will include discussion of omaveloxolone.
Answered 18 Nov 2026
Original Parliament recordFriedreich's Ataxia: DrugsDepartment of Health and Social CareTabled 10 Nov 2026AnsweredUIN 41439More
Question: To ask the Secretary of State for Health and Social Care, what progress her Department, NICE and Biogen have made on access to treatments for people living with Friedreich's Ataxia.
Answer: I refer the Rt Hon. Member to the answer provided on 26 October in response to Question 36046.At the request of Biogen, NHS England has offered to hold a commercial surgery with the company in December, which will include discussion of omaveloxolone.
Answered 18 Nov 2026
Original Parliament recordFriedreich's Ataxia: DrugsDepartment of Health and Social CareTabled 10 Nov 2026AnsweredUIN 41438More
Question: To ask the Secretary of State for Health and Social Care, what progress has been made in reaching an agreement with Biogen and NICE to allow eligible patients in England to access treatments for Freidreich's Ataxia promptly; and if she will make a stateme
Answer: I refer the Rt Hon. Member to the answer provided on 26 October in response to Question 36046.At the request of Biogen, NHS England has offered to hold a commercial surgery with the company in December, which will include discussion of omaveloxolone.
Answered 18 Nov 2026
Original Parliament recordHydrocortisone: ChildrenDepartment of Health and Social CareTabled 10 Nov 2026AnsweredUIN 41432More
Question: To ask the Secretary of State for Health and Social Care, if she will consider issuing guidance to schools and early years settings on supporting children with adrenal insufficiency and administering emergency hydrocortisone.
Answer: I refer the Rt Hon. Member and the Hon. Member to the response given on 22 April to Question 126862, and to the response given on 25 June to Question 9822.
Answered 17 Nov 2026
Original Parliament recordHydrocortisoneDepartment of Health and Social CareTabled 10 Nov 2026AnsweredUIN 41431More
Question: To ask the Secretary of State for Health and Social Care, what steps the Government is taking to support the development and availability of a user-friendly emergency cortisol injection device for adrenal insufficiency.
Answer: I refer the Rt Hon. Member and the Hon. Member to the response given on 22 April to Question 126862, and to the response given on 25 June to Question 9822.
Answered 17 Nov 2026
Original Parliament recordHydrocortisoneDepartment of Health and Social CareTabled 10 Nov 2026AnsweredUIN 41430More
Question: To ask the Secretary of State for Health and Social Care, if her Department will take steps with regulators and manufacturers to accelerate access to easier-to-use emergency hydrocortisone products, including dual-chamber systems and prefilled injection d
Answer: I refer the Rt Hon. Member and the Hon. Member to the response given on 22 April to Question 126862, and to the response given on 25 June to Question 9822.
Answered 17 Nov 2026
Original Parliament recordHydrocortisoneDepartment of Health and Social CareTabled 10 Nov 2026AnsweredUIN 41429More
Question: To ask the Secretary of State for Health and Social Care, what discussions have taken place between the Government, the Medicines and Healthcare products Regulatory Agency (MHRA) and manufacturers to make emergency hydrocortisone preparations available to
Answer: I refer the Rt Hon. Member and the Hon. Member to the response given on 22 April to Question 126862, and to the response given on 25 June to Question 9822.
Answered 17 Nov 2026
Original Parliament recordHydrocortisoneDepartment of Health and Social CareTabled 10 Nov 2026AnsweredUIN 41428More
Question: To ask the Secretary of State for Health and Social Care, whether the dual-chamber Act-O-Vial hydrocortisone injection system has been submitted for licensing in the UK and if she will make a statement.
Answer: I refer the Rt Hon. Member and the Hon. Member to the response given on 22 April to Question 126862, and to the response given on 25 June to Question 9822.
Answered 17 Nov 2026
Original Parliament recordPregnancy: DrugsDepartment of Health and Social CareTabled 10 Nov 2026AnsweredUIN 41424More
Question: To ask the Secretary of State for Health and Social Care, when the independent evaluation of the fetal exposure to medicines pilot will be published.
Answer: The independent evaluation of the Fetal Exposure to Medicines Service pilot project is due to be completed in Spring 2028.
Answered 19 Nov 2026
Original Parliament recordSodium Valproate: CompensationDepartment of Health and Social CareTabled 10 Nov 2026AnsweredUIN 41423More
Question: To ask the Secretary of State for Health and Social Care, by what date will a decision be taken on financial redress for those impacted by sodium valproate.
Answer: I refer the Rt Hon. Member to my response in the House to the Adjournment debate on 29 October, where I addressed these questions at length.
Answered 16 Nov 2026
Original Parliament recordSodium Valproate and Surgical Mesh ImplantsDepartment of Health and Social CareTabled 10 Nov 2026AnsweredUIN 41422More
Question: To ask the Secretary of State for Health and Social Care, when her Department will publish its formal response to the Hughes Report.
Answer: I refer the Rt Hon. Member to my response in the House to the Adjournment debate on 29 October, where I addressed these questions at length.
Answered 16 Nov 2026
Original Parliament record
Explore activity by topic or department
Written questions by answering department
4 Jul 2026–22 Nov 2026. One record per UIN and tabled date; the named department is not a measure of answer quality.
View as listWhat this shows and doesn't show
| Department or topic | Published records |
|---|---|
| Department for Work and Pensions | 1 |
| Department of Health and Social Care | 11 |
| Home Office | 1 |
| Ministry of Defence | 2 |
| Ministry of Housing, Communities and Local Government | 3 |
Published records only — not a full account of an MP’s work. How we work →